These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14655471)

  • 21. Bulletin board. Neoadjuvant radiotherapy halves local recurrence rate of rectal cancer in major study.
    Future Oncol; 2010 Dec; 6(12):1824. PubMed ID: 21142855
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.
    Glynne-Jones R; Sebag-Montefiore D
    J Clin Oncol; 2006 Oct; 24(28):4664-5; author reply 4665-6. PubMed ID: 17008708
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction "by half". The need for standardised surgical technique in studies of radiotherapy for rectal cancer.
    Wiggers T; van de Velde CH
    Eur J Surg; 1999 May; 165(5):407-9. PubMed ID: 10391154
    [No Abstract]   [Full Text] [Related]  

  • 24. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?
    Martijn H; Vulto JC
    Eur J Cancer; 2007 Oct; 43(15):2301-6. PubMed ID: 17714937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 29. Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy.
    Saito N; Ono M; Sugito M; Ito M; Morihiro M; Kosugi C; Sato K; Kotaka M; Nomura S; Arai M; Kobatake T
    Dis Colon Rectum; 2004 Apr; 47(4):459-66. PubMed ID: 14978613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy.
    Habr-Gama A
    Colorectal Dis; 2006 Sep; 8 Suppl 3():21-4. PubMed ID: 16813588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiotherapy for rectal cancer.
    Moesta KT; Köckerling F
    Br J Surg; 2006 Sep; 93(9):1035-7. PubMed ID: 16915590
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant therapy in rectal cancer: what is the truth?
    Takiuchi H
    Jpn J Clin Oncol; 2006 Apr; 36(4):191-2. PubMed ID: 16684858
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefits, limitations, and harm of local excision for rectal cancer.
    Ziogas D; Tsekeris P; Fatourou E
    Ann Surg Oncol; 2008 Sep; 15(9):2628-9; author reply 2630-1. PubMed ID: 18347876
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
    Junginger T; Hermanek P; Oberholzer K; Schmidberger H
    Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neoadjuvant and adjuvant therapies for solid tumours].
    Heinemann V; Moosmann N
    MMW Fortschr Med; 2007 Sep; 149(35-36):27-30. PubMed ID: 17944281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidisciplinary treatment of resectable rectal cancer.
    Ayala DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-operative management of rectal cancer after neoadjuvant chemoradiation.
    Habr-Gama A; Perez RO
    Br J Surg; 2009 Feb; 96(2):125-7. PubMed ID: 19160360
    [No Abstract]   [Full Text] [Related]  

  • 39. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors.
    Shivnani AT; Small W; Stryker SJ; Kiel KD; Lim S; Halverson AL; Talamonti MS
    Am J Surg; 2007 Mar; 193(3):389-93; discussion 393-4. PubMed ID: 17320541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rectal cancer margin].
    Rivoire M; Malerba M; Gandini A
    Bull Cancer; 2008 Dec; 95(12):1177-81. PubMed ID: 19091651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.